Literature DB >> 22959733

Reducing cost by reducing polypharmacy: the polypharmacy outcomes project.

Gotaro Kojima1, Christina Bell, Bruce Tamura, Michiko Inaba, Karen Lubimir, Patricia Lanoie Blanchette, Wendy Iwasaki, Kamal Masaki.   

Abstract

OBJECTIVE: To examine the effect of intervention by geriatric medicine fellows and a geriatrician on medication cost among long term care residents with polypharmacy.
DESIGN: Interventional study.
SETTING: A single hospital-affiliated long term care facility. PARTICIPANTS: Long term care residents with polypharmacy, defined as being on 9 or more medications. INTERVENTION: Medication lists of all nursing home residents were reviewed in October 2007 by geriatric medicine fellows and a faculty geriatrician using the 2003 Beers Criteria and the Epocrates online drug-drug interaction program. Recommendations for each resident were prepared and discussed directly with their primary physicians, who made the final decisions regarding medication discontinuation or taper. MEASUREMENTS: Mean monthly costs (derived from current retail prices) for overall as well as scheduled and pro re nata (PRN) medications were compared before and after the intervention. Estimated reduction in nursing administration time and cost were calculated based on published literature on medication administration time and nursing labor costs.
RESULTS: Seventy-four (46.3%) of 160 residents were on 9 or more medications. Four residents died or were discharged before the intervention, leaving a final sample of 70 residents for the intervention. After the intervention, mean monthly medication costs per resident significantly decreased; overall medications, from $874.27 to $843.56 (P < .0001); scheduled medications, from $814.05 to $801.14 (P= .007); PRN medications, from $60.22 to $42.43 (P < .0001). Gastrointestinal medications demonstrated the highest cost savings of all medication categories (eg, promethazine and proton pump inhibitors), followed by central nervous system-active medications (including benzodiazepines and fluoxetine), then analgesics and diabetes medications.
CONCLUSION: This polypharmacy reduction intervention by physicians used readily available tools, demonstrated a significant decrease in medication-related costs, and provided training in the core competencies of practice-based learning and improvement and systems-based practice to geriatric medicine fellows in long term care.
Copyright © 2012 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22959733      PMCID: PMC3489959          DOI: 10.1016/j.jamda.2012.07.019

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  28 in total

1.  Risk factors for adverse drug events among nursing home residents.

Authors:  T S Field; J H Gurwitz; J Avorn; D McCormick; S Jain; M Eckler; M Benser; D W Bates
Journal:  Arch Intern Med       Date:  2001-07-09

2.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

3.  Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics.

Authors:  Denys T Lau; Judith D Kasper; D E B Potter; Alan Lyles
Journal:  Health Serv Res       Date:  2004-10       Impact factor: 3.402

Review 4.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

Review 5.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Authors:  M H Beers; J G Ouslander; I Rollingher; D B Reuben; J Brooks; J C Beck
Journal:  Arch Intern Med       Date:  1991-09

6.  Consultant pharmacist drug therapy recommendations from monthly drug regimen reviews in a geriatric nursing facility: a two-year study and cost analysis.

Authors:  J W Cooper
Journal:  J Nutr Health Aging       Date:  1997       Impact factor: 4.075

Review 7.  Drug use in the nursing home.

Authors:  J Avorn; J H Gurwitz
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

8.  Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).

Authors:  Graziano Onder; Claudio Pedone; Francesco Landi; Matteo Cesari; Cecilia Della Vedova; Roberto Bernabei; Giovanni Gambassi
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

9.  Polypharmacy as a risk for fall occurrence in geriatric outpatients.

Authors:  Taro Kojima; Masahiro Akishita; Tetsuro Nakamura; Kazushi Nomura; Sumito Ogawa; Katsuya Iijima; Masato Eto; Yasuyoshi Ouchi
Journal:  Geriatr Gerontol Int       Date:  2011-12-23       Impact factor: 2.730

Review 10.  Medication use in nursing homes for elderly people.

Authors:  L Furniss; S K Craig; A Burns
Journal:  Int J Geriatr Psychiatry       Date:  1998-07       Impact factor: 3.485

View more
  33 in total

Review 1.  Frailty in Hematologic Malignancy.

Authors:  Thuy T Koll; Ashley E Rosko
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

2.  The impact of telemental health use on healthcare costs among commercially insured adults with mental health conditions.

Authors:  Xiaohui Zhao; Sandipan Bhattacharjee; Kim E Innes; Traci J LeMasters; Nilanjana Dwibedi; Usha Sambamoorthi
Journal:  Curr Med Res Opin       Date:  2020-08-07       Impact factor: 2.580

3.  Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study.

Authors:  Eva Mann; Burkhard Haastert; Birgit Böhmdorfer; Thomas Frühwald; Bernhard Iglseder; Regina Roller-Wirnsberger; Gabriele Meyer
Journal:  Wien Klin Wochenschr       Date:  2013-03-28       Impact factor: 1.704

4.  Refractory primary medication nonadherence: Prevalence and predictors after pharmacist counseling at hospital discharge.

Authors:  Kathleene Wooldridge; Jeffrey L Schnipper; Kathryn Goggins; Robert S Dittus; Sunil Kripalani
Journal:  J Hosp Med       Date:  2015-08-21       Impact factor: 2.960

5.  Assessing an Interprofessional Polypharmacy and Deprescribing Educational Intervention for Primary Care Post-graduate Trainees: a Quantitative and Qualitative Evaluation.

Authors:  Marcia C Mecca; John M Thomas; Kristina M Niehoff; Anne Hyson; Sean M Jeffery; John Sellinger; Adam P Mecca; Peter H Van Ness; Terri R Fried; Rebecca Brienza
Journal:  J Gen Intern Med       Date:  2019-04-10       Impact factor: 5.128

6.  Editorial: Frailty and Polypharmacy.

Authors:  Y Rolland; J E Morley
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

7.  Excessive polypharmacy and survival in polypathological patients.

Authors:  Jesús Díez-Manglano; Mercedes Giménez-López; Vanesa Garcés-Horna; María Sevil-Puras; Elena Castellar-Otín; Paloma González-García; Isabel Fiteni-Mera; Teresa Morlanes-Navarro
Journal:  Eur J Clin Pharmacol       Date:  2015-04-26       Impact factor: 2.953

Review 8.  Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.

Authors:  Kasia J Lipska; Harlan Krumholz; Tacara Soones; Sei J Lee
Journal:  JAMA       Date:  2016-03-08       Impact factor: 56.272

9.  Opioid prescribing and risk of drug-opioid interactions in older discharged patients with polypharmacy in Australia.

Authors:  Aymen Ali Al-Qurain; Lemlem G Gebremichael; Mohammed S Khan; Desmond B Williams; Lorraine Mackenzie; Craig Phillips; Patrick Russell; Michael S Roberts; Michael D Wiese
Journal:  Int J Clin Pharm       Date:  2020-11-18

10.  Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation.

Authors:  Philipe de Souto Barreto; Maryse Lapeyre-Mestre; Philippe Cestac; Bruno Vellas; Yves Rolland
Journal:  Br J Clin Pharmacol       Date:  2016-01-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.